For the next eight years, NYU Langone Health will leverage technologies by Philips to create real-time interoperability and information sharing among its different departments to facilitate faster diagnoses and treatments for increasing chances of better patient outcomes.

NYU Langone Health will enhance communication among radiologists, pathologists, surgeons, and more with Philips Patient Information Center iX, a standards-based central monitoring system, and Philips Capsule Medical Device Information Platform, which brings together different sources of data from medical devices and systems, including third-party solutions, into a single unified view.

Back in October, Philips announced it had made both solutions interoperable with one another, creating an open, scalable, secure platform whereby data is disseminated through the Patient Information Center iX to provide clinicians with a single source, comprehensive overview of a patient’s condition. NYU Langone Health will use the integrated technologies to create an enterprise monitoring platform and business model, which it expects in the long term will improve patient experiences and staff productivity, while making care more affordable for providers and patients.

"As hospitals and health systems accelerate efforts for patient-centric, clinician-centric care delivery, a patient monitoring ecosystem is required, allowing caregivers to fully leverage investments in medical device solutions, workflow optimization approaches, and digital technologies," Julia Strandberg, chief business leader for Connected Care at Philips, told HCB News.

According to Strandberg, medical device integration allows providers to standardize and personalize care across acuities and disease pathways, leading to better workflows, care delivery, and patient safety, and in turn, lower care costs. In creating unified access to patient data from anywhere, these solutions enable clinicians to make quick, informed decisions regardless of their location. Interoperability and data sharing are also key components for communication, collaboration, and mobility of solutions and platforms; the adoption of digital technologies; and the creation of new care models that better alleviate staffing shortage challenges.

When combined in a predictable Enterprise Monitoring as a Services (EMaaS) subscription model, Philips MDIP and PIC iX solutions allow for information to be captured and flow freely across hospital networks. By sharing information and communicating with one another in a single platform in real time, clinicians are better able to make decisions together and tailor care to individuals, according to Philips.

Philips iX is scalable and supports a shared IT infrastructure among different departments. Clinicians can view monitoring history, from the ED to telemetry floors and during transport, and multiple security mechanisms, including user authentication and authorization, protect data integrity and confidentiality. It also has end-to-end clinical data analytics capabilities for high-resolution physiologic data acquisition, archiving, and access.

Also scalable, healthcare providers can continue adding new types of medical devices with Philips Capsule MDIP, which monitors, aggregates, and compiles data in a single interface that enables better prioritization and coordination of interventions. Additionally, NYU Langone Health will adopt Philips’ IntelliSite Pathology solution, for open and scalable pathology-based IT infrastructures and workflows; enterprise informatics; and AI-enabled diagnostic imaging technologies such as the Philips Lumify Handheld Ultrasound.

“Our access to transformative healthcare technologies developed by Philips will provide our researchers with countless opportunities to advance knowledge and develop new diagnostic and treatment modalities that enhance patient care, safety, and outcomes,” said NYU Langone’s chief scientific officer, executive vice president, and vice dean for Science Dr. Dafna Bar-Sagi, in a statement.